The Exchange had sought clarification from Zota Health Care LImited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI. The response of the Company is enclosed.
ZOTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The National Stock Exchange of India sought clarification from Zota Health Care Limited regarding their Q2 FY26 financial results submission under SEBI Regulation 33. Two issues were identified: (1) the balance sheet had incorrect comparative period data, showing September 2024 figures instead of the required March 2025 data, and (2) the financial results were not submitted in machine-readable format. The company responded that both issues occurred due to inadvertent oversight and have now been corrected. The company confirmed that no changes were made to the actual financial figures, which remain unchanged from the original submission. The auditors also provided a clean review report confirming the results comply with applicable accounting standards.
Minimal impact on shareholders as this is a procedural formatting correction with no change to financial figures. The company has resolved the SEBI compliance issue by resubmitting the results in the correct format.